The therapeutic effects of EPO are attributed to the direct action of its component EFAs on immune cells as well as their indirect effect on the synthesis of eicosanoids (e.g., prostaglandins, cytokines, cytokine mediators), which are significantly high in mastalgia [13]. The gene discussed is EPO; the disease is mastodynia.